Les raisons pour lesquelles l’OMS a besoin d’une réévaluation de son approche draconienne en matière de cannabis

L’OMS pourrait montrer qu’elle se soucie du cannabis et des millions de personnes qui en utilisent en réduisant les dommages sociaux et sanitaires causés par la politique internationale actuelle.

Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

Cannabis is hugely popular. 182m people use cannabis across the world and, with this level of exposure, the way cannabis is regulated matters. As does the evidence of risks and benefits to health which underpins regulation.

Sometimes saying nothing is as telling as saying something. Silence can suggest retaining the status quo. The World Health Organisation (WHO) has been silent about the international regulatory controls on cannabis since its inception in 1935. The past 80 years have brought dramatic advances in scientific knowledge about cannabis, so it is odd that it has not provided updated advice about its legal status.

Indeed, cannabis continues to be scheduled in the same legal category as morphine – despite opiates such as morphine being more harmful, as recent drug fatality data reveals.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Thumbnail: WikiMedia CC EVAN-AMOS